UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


                          Date of Report: May 12, 2005

                       (Date of earliest event reported):


                              INNODATA ISOGEN, INC.
             (Exact name of registrant as specified in its charter)


            Delaware                    0-22196                13-3475943
(State or other jurisdiction of  (Commission File Number)    (I.R.S. Employer
         incorporation)            Identification No.)


           Three University Plaza                                   07601
            Hackensack, NJ 07601                                  (Zip Code)
  (Address of principal executive offices)


                                 (201) 488-1200
              (Registrant's telephone number, including area code)

                                       N/A
          (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

|_|  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))





Item 2.02  Results of Operations and Financial Condition.

     On May 12, 2005, Innodata Isogen, Inc. issued a press release announcing
its first quarter 2005 financial results. A copy of the press release is
attached hereto as Exhibit 99.1.

     In accordance with General Instruction B.2 of Form 8-K, the information in
this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to
be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or otherwise subject to the liability of that
section, and shall not be incorporated by reference into any registration
statement or other document filed under the Securities Act of 1933, as amended,
or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.


Item 9.01  Financial Statements and Exhibits.


99.1              Press release dated May 12, 2005.


                                       2









                                   SIGNATURES

       Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
                                            INNODATA ISOGEN, INC.



Date:  May 12, 2005                         By:  Stephen Agress
                                            ------------------------------
                                                 Stephen Agress
                                                 Vice President, Finance


                                       3





                                INDEX TO EXHIBITS


    Exhibit No.          Description
    -----------          ------------
         99.1             Press Release of Innodata Isogen, Inc.,
                          dated May 12, 2005, reporting
                          first quarter 2005 financial results.


                                       4